OMX Nordic 40
2.412,36
PKT
+56,32
PKT
+2,39
%
Werbung
Analysen zu OMX Nordic 40-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 18.03.21 | Nokia Neutral | JP Morgan Chase & Co. | |
| 17.03.21 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 17.03.21 | Nokia buy | Kepler Cheuvreux | |
| 16.03.21 | Hennes Mauritz (H M, H&M) buy | Kepler Cheuvreux | |
| 16.03.21 | Novo Nordisk buy | Deutsche Bank AG | |
| 16.03.21 | Nokia Neutral | Goldman Sachs Group Inc. | |
| 16.03.21 | Nokia Neutral | JP Morgan Chase & Co. | |
| 16.03.21 | AstraZeneca buy | Jefferies & Company Inc. | |
| 10.03.21 | A.P. Moeller - Maersk A-S (B) Outperform | Credit Suisse Group | |
| 09.03.21 | Volvo (B) buy | Kepler Cheuvreux | |
| 08.03.21 | AstraZeneca buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 08.03.21 | AstraZeneca kaufen | Barclays Capital | |
| 06.03.21 | ABB (Asea Brown Boveri) Sector Perform | RBC Capital Markets | |
| 05.03.21 | Nokia Neutral | Credit Suisse Group | |
| 05.03.21 | Novo Nordisk buy | Deutsche Bank AG | |
| 04.03.21 | Novo Nordisk Conviction Buy | Goldman Sachs Group Inc. | |
| 04.03.21 | Kone Neutral | Goldman Sachs Group Inc. | |
| 02.03.21 | AstraZeneca buy | UBS AG | |
| 02.03.21 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 25.02.21 | AstraZeneca buy | UBS AG | |
| 22.02.21 | A.P. Moeller - Maersk A-S (B) buy | UBS AG | |
| 19.02.21 | Volvo (B) Reduce | Kepler Cheuvreux | |
| 19.02.21 | Volvo (B) Conviction Buy List | Goldman Sachs Group Inc. | |
| 18.02.21 | Novo Nordisk Neutral | UBS AG | |
| 18.02.21 | AstraZeneca Neutral | UBS AG | |
| 17.02.21 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 16.02.21 | Novo Nordisk buy | Deutsche Bank AG | |
| 16.02.21 | AstraZeneca buy | Deutsche Bank AG | |
| 15.02.21 | A.P. Moeller - Maersk A-S (B) buy | Goldman Sachs Group Inc. | |
| 15.02.21 | A.P. Moeller - Maersk A-S (B) Outperform | Credit Suisse Group | |
| 15.02.21 | AstraZeneca buy | Deutsche Bank AG | |
| 15.02.21 | Nokia Neutral | Goldman Sachs Group Inc. | |
| 12.02.21 | AstraZeneca buy | Deutsche Bank AG | |
| 12.02.21 | AstraZeneca Outperform | Credit Suisse Group | |
| 11.02.21 | ABB (Asea Brown Boveri) buy | UBS AG | |
| 11.02.21 | A.P. Moeller - Maersk A-S (B) buy | UBS AG | |
| 11.02.21 | AstraZeneca overweight | Barclays Capital | |
| 11.02.21 | AstraZeneca Neutral | UBS AG | |
| 11.02.21 | Nokia Neutral | Credit Suisse Group | |
| 11.02.21 | A.P. Moeller - Maersk A-S (B) buy | Jefferies & Company Inc. |